Format

Send to

Choose Destination
See comment in PubMed Commons below
Oral Maxillofac Surg Clin North Am. 2014 Feb;26(1):75-81. doi: 10.1016/j.coms.2013.09.006.

Salivary gland disease in Sjögren's syndrome: sialoadenitis to lymphoma.

Author information

1
New York Center for Salivary Gland Diseases, Head and Neck Institute, Beth Israel Medical Center, New York, NY 10003, USA; Oral and Maxillofacial Surgery, Jacobi Medical Center, Bronx, NY 10461, USA. Electronic address: mturner@chpnet.org.

Abstract

Although the cause and molecular pathways of Sjögren's syndrome are still unknown, basic, clinical, and translational science have started to identify linkages to other known processes. With the advent of newer, more sensitive, and more accurate chemokine, cytokine, and genetic analysis, the molecular progression of the disease may be understood. The modern technology of sialoendoscopy to treat obstructive sialoadenitis from mucous plugging, and the addition of rituximab to current chemotherapy, have allowed patients with Sjögren's syndrome to have a better quality of life and, if they develop lymphomatous changes, a significant increase in their disease remission and survival rate.

KEYWORDS:

Autoimmune diseases; Lymphoma; Sialoadenitis; Sialoendoscopy; Sjögren's syndrome

PMID:
24287195
DOI:
10.1016/j.coms.2013.09.006
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center